Definium Therapeutics Inc. DFTX on Monday released topline results from Panorama, its second Phase 3 study evaluating DT120 ...

The company has filed an NDA with US regulators for Voxzogo in hypochondroplasia following these positive results.

Scientists have developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method significantly enhances anti-tumor efficacy. A team of ...

Chemotherapy drugs that target cancer cells without damaging normal cells remain one of the key goals of precision medicine in cancer treatment. The challenge is designing drugs that do this ...

Researchers at the University of Michigan have developed a mathematical model that reveals how our circadian rhythms can have dramatic impacts on how our bodies interact with medicines. This could ...

In new patients, disability score changes were similar over 2 years regardless of treatmen ...

The European Medicines Agency (EMA) has published a guideline on evaluating drug interactions in the gastrointestinal tract ...

A new method seeks specific molecules that can target desired tissues through the bloodstream and penetrate tissues by passing through cells. This innovation could help solve issues related to drug ...

Molecular crystal polymorphism does not sound like something you want in your kitchen, but you've probably had experience with it. Like that time you left a chocolate bar lying around for months, only ...

Jan 15 (Reuters) - The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's ‌new fast-track program after agency scientists flagged safety and ...